Long-Term Air Pollution Exposure Tied to Higher Depression, Anxiety Risk

MONDAY, Feb. 6, 2023 (HealthDay News) -- Long-term exposure to multiple air pollutants is associated with an increased risk for depression and anxiety, according to a study published online Feb. 1 in JAMA Psychiatry.
Teng Yang, from Peking University in Beijing, and colleagues examined the association of long-term exposure to multiple air pollutants with incident depression and anxiety. The analysis included data from 389,185 participants in the U.K. Biobank followed for a median 10.9 years.
The researchers found that long-term estimated exposure to multiple air pollutants was associated with an increased risk for depression and anxiety, and the exposure-response curves were nonlinear, with steeper slopes at lower concentrations and plateauing trends at higher exposure. For depression and anxiety, the hazard ratios (HRs) were 1.16 and 1.11 in the highest quartile versus the lowest quartile of air pollution score, respectively. For fine particulate matter (PM2.5), nitrogen dioxide, and nitric oxide, findings were similar. The association between PM2.5 and anxiety tended to be higher in male individuals versus female individuals (quartile 4, male individuals: HR, 1.18; female individuals: HR,1.07).
“Increased associated risk for both depression and anxiety was observed even at concentration levels below the annual values in UK air quality standards,” the authors write. “Thus, the findings suggest that stricter standards or regulations for air pollution control are essential, and reductions in exposure to multiple air pollutants may alleviate the disease burden of depression and anxiety.”
Abstract/Full Text (subscription or payment may be required)
Related Posts
Tuvieron muchos problemas, pero la pandemia no fue del todo mala para las nuevas mamás
LUNES, 21 de febrero de 2022 (HealthDay News) -- Aunque las nuevas mamás se han...
Elimination Diets Aid Eczema Severity Only Modestly
TUESDAY, July 26, 2022 (HealthDay News) -- Elimination diets may be associated...
FDA Limits Use of J&J COVID Vaccine Due to Blood Clot Risk
THURSDAY, May 5, 2022 (HealthDay News) -- Citing the accumulated data on a...
La mayoría de las personas con COVID prolongada tienen síntomas 15 meses después
MIÉRCOLES, 25 de mayo de 2022 (HealthDay News) -- Muchos pacientes con COVID-19...
